Current Scenario of Clinical Cancer Research in Latin America and the Caribbean

In Latin America and the Caribbean (LAC), progress has been made in some national and regional cancer control initiatives, which have proved useful in reducing diagnostic and treatment initiation delays. However, there are still significant gaps, including a lack of oncology clinical trials. In this...

Full description

Saved in:
Bibliographic Details
Published in:Current oncology (Toronto) 2023-01, Vol.30 (1), p.653-662
Main Authors: Gössling, Gustavo, Rebelatto, Taiane F, Villarreal-Garza, Cynthia, Ferrigno, Ana S, Bretel, Denisse, Sala, Raul, Giacomazzi, Juliana, William, Jr, William N, Werutsky, Gustavo
Format: Article
Language:English
Subjects:
cancer
Caribbean
Caribbean Region - epidemiology
clinical trials
Humans
Latin America
Latin America - epidemiology
Medical Oncology
Neoplasms - therapy
Review
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In Latin America and the Caribbean (LAC), progress has been made in some national and regional cancer control initiatives, which have proved useful in reducing diagnostic and treatment initiation delays. However, there are still significant gaps, including a lack of oncology clinical trials. In this article, we will introduce the current status of the region's clinical research in cancer, with a special focus on academic cancer research groups and investigator-initiated research (IIR) initiatives. Investigators in LAC have strived to improve cancer research despite drawbacks and difficulties in funding, regulatory timelines, and a skilled workforce. Progress has been observed in the representation of this region in clinical trial development and conduct, as well as in scientific productivity. However, most oncology trials in the region have been sponsored by pharmaceutical companies, highlighting the need for increased funding from governments and private foundations. Improvements in obtaining and/or strengthening the LAC cancer research group's financing will provide opportunities to address cancer therapies and management shortcomings specific to the region. Furthermore, by including this large, ethnic, and genetically diverse population in the world's research agenda, one may bridge the gap in knowledge regarding the applicability of results of clinical trials now mainly conducted in populations from the Northern Hemisphere.
ISSN:1718-7729
1198-0052
1718-7729
DOI:10.3390/curroncol30010050